Sarepta Therapeutics announced a significant change in leadership following a challenging financial year. The company’s latest earnings report revealed an adjusted loss of $3.58...
Abbott Laboratories (NYSE:ABT) faced a significant adjustment from Evercore ISI, which lowered its price target from $144 to $138 on January 23, 2024. Despite...
UPDATE: Wall Street’s momentum is stalling as stocks face a significant dip today, September 27, 2023. The Dow Jones Industrial Average has plunged 332...